What the public record says
The TGA warns that unapproved peptide products with unclear labelling, code-only identification, omitted ingredients, obscured information, or unlabelled vials may not be considered for release under the Personal Importation Scheme. A joint ABF/TGA release in April 2026 also reported seizures of PIEDs, steroids, and peptide products in an alleged importation syndicate investigation.
What buyers should check
- Ask where the first tracking scan begins, not just where the website says it ships.
- Treat code-only labels as a serious verification problem.
- Save the product page, invoice, tracking, and support replies before payment if the dispatch route is unclear.
- Do not treat research-use language as an import shield.
- The safer pre-payment question is: can this vendor explain the import, prescription, research, or pharmacy pathway with sources?
Source links
Use this regulatory brief to ask better supplier questions. Do not convert a market-level warning into a vendor-specific claim unless the vendor page has a source attached.
Open vendor scorecards